Reuters logo
BRIEF-Asterias Biotherapeutics Q4 loss per share $0.20
March 28, 2017 / 8:12 PM / 6 months ago

BRIEF-Asterias Biotherapeutics Q4 loss per share $0.20

March 28 (Reuters) - Asterias Biotherapeutics Inc:

* Asterias Biotherapeutics reports fourth quarter and full year 2016 financial results and highlights recent development progress

* Q4 loss per share $0.20

* Q4 revenue $1.8 million

* Q4 revenue view $2.6 million -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

* Asterias Biotherapeutics Inc- “believe we currently have sufficient capital to fund operations through at least q1 of 2018” Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below